+44 (0) 1698 534002
Contact

News

BioAscent works with University of Edinburgh to form a unique set of compounds

24 September 2021

BioAscent worked closely with Edinburgh Cancer Research Centre (ECRC) at the University of Edinburgh to purchase a set o...

Read more

BioAscent invests in second Biacore 8K machine to meet growing customer demand for expert SPR services

24 September 2021

BioAscent has invested in a second Biacore 8k SPR System, further enhancing its biophysical assay development and screen...

Read more

Triathlon preparation during a pandemic: A personal challenge

31 August 2021

Stuart McElroy, Director of Biosciences at BioAscent will be undertaking the 2021 European Sprint Distance Triathlon Cha...

Read more

Dr Phil Jones presents at BOS Virtual 2021

10 August 2021

BioAscent’s Chief Scientific Officer, Dr Phil Jones, joined industry colleagues to discuss the integrated drug discovery...

Read more

Podcast: What in the Life Sciences?

28 June 2021

Dr Phil Jones, CSO at BioAscent, recently joined Roland Linder on the Scottish Development International’s podcast serie...

Read more

New fragments suggested by machine learning

22 June 2021

BioAscent’s Associate Director of In Silico Discovery and Data Analysis, Dr Angelo Pugliese, is the corresponding author...

Read more

BioAscent enhances its computational chemistry services

04 May 2021

BioAscent, the UK's fastest-growing integrated drug discovery CRO, has appointed Dr Angelo Pugliese as Associate Di...

Read more

Recognition for Glasgow Lighthouse Laboratory

22 April 2021

The Glasgow Lighthouse Laboratory has picked up the COVID-19 Collaborative Response Award at this year’s Scottish Knowle...

Read more

BioAscent picks up the Business Leadership Award at Scotland’s Life Sciences Awards

25 March 2021

The virtual awards ceremony recognised businesses and achievements from across Scotland’s life sciences sector. Original...

Read more

Presentation: Innovative Assays for Hit Confirmation

19 March 2021

In this short presentation, Dr Phil Jones, Chief Scientific Officer at BioAscent, discusses an innovative assay that was...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact